Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bala Gur Dedeoglu

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Oncology|May 8, 2026
miR-99b-5p inhibition drives apoptosis and tumor shrinkage in triple-negative breast cancer: functional characterization through AGO2-RIP-seq and mechanistic insightsSenem Noyan, Kubra Nur Kaplan Ilhan, Muge Ocal Demirtas, et al.
Leukemia Research|November 6, 2017
DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemiaHakan Ozdogan, Bala Gur Dedeoglu, Yasemin Oztemur Islakoglu, et al.
Plos One|June 30, 2010
The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneityMine Mumcuoglu, Sevgi Bagislar, Haluk Yuzugullu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Oncology|May 8, 2026
miR-99b-5p inhibition drives apoptosis and tumor shrinkage in triple-negative breast cancer: functional characterization through AGO2-RIP-seq and mechanistic insightsSenem Noyan, Kubra Nur Kaplan Ilhan, Muge Ocal Demirtas, et al.
Leukemia Research|November 6, 2017
DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemiaHakan Ozdogan, Bala Gur Dedeoglu, Yasemin Oztemur Islakoglu, et al.
Plos One|June 30, 2010
The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneityMine Mumcuoglu, Sevgi Bagislar, Haluk Yuzugullu, et al.
Pageof 3